Industry Experts

Michelle Hussong is leading the cell line development R&D Team at Cytiva, where she drives strategic initiatives in viral vectors manufacturing, drawing on over ten years of experience in molecular and cell biology.

Before her current role, Michelle held a scientific team lead position at CEVEC Pharmaceuticals, where she advanced bioanalytical assay development, improving analytical processes and establishing high-throughput platforms that enhance the efficiency and accuracy of cell line development. Michelle holds a PhD in Cellular and Molecular Biology from Freie Universität Berlin, where she conducted impactful research on epigenetic regulation during malignant transformation at the Max Planck Institute for Molecular Genetics, deepening her expertise in genomics.